Sign In

Eleonora Trotta

Principal Scientist at Sonoma Biotherapeutics

Eleonora Trotta is a Principal Scientist at Sonoma Biotherapeutics with extensive experience in immunological sciences and biotechnology.2 She holds a Ph.D. and has a strong background in Medical, Molecular, and Cellular Biotechnologies.

Dr. Trotta's work focuses on autoimmune diseases, particularly Type I diabetes, as evidenced by her research citations.4 She has been involved in collaborative research efforts, including work on regulatory T cells for combating autoimmune diseases at the University of California, San Francisco (UCSF).1

At Sonoma Biotherapeutics, Dr. Trotta is engaged in cutting-edge research and development of Treg cell therapies. In March 2023, she shared news about a collaboration between Sonoma Biotherapeutics and Regeneron to discover, develop, and commercialize Treg cell therapies3, highlighting her involvement in advancing innovative treatments for autoimmune disorders.

Highlights

Mar 1 · med.stanford.edu
Workaround erases side effects of promising cell-based cancer ...

Related Questions

What are Eleonora Trotta's main research interests?
How did Eleonora Trotta transition from UCSF to Sonoma Biotherapeutics?
What specific projects is Eleonora Trotta currently working on at Sonoma Biotherapeutics?
Can you provide more details about the collaboration between Sonoma Biotherapeutics and Regeneron?
What are Eleonora Trotta's educational background and qualifications?
Eleonora Trotta
Eleonora Trotta, photo 1
Eleonora Trotta, photo 2
Add to my network

Location

San Francisco, California, United States